Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy
- 1st Edition, Volume 165 - May 1, 2025
- Editors: Arun Kumar Singh, Neeraj Mishra, Sumel Ashique, Pranav Kumar Prabhakar
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 3 4 4 9 5 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 4 4 9 6 - 1
Advances in Immunology, Volume 165, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immuno… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote- Presents current developments and comprehensive reviews in immunology
- Provides the latest in a longstanding and respected serial on the subject matter
- Focuses on recent advances in the field of immunology
2. Nanoparticles for mRNA-based cancer immunotherapy
3. Nucleic acid Delivery as a therapeutic approach in cancer immunotherapy
4. Plasmid DNA and mRNA: Delivery approaches and challenges
5. Viral & Non-viral Delivery of mRNA against Cancer Cell
6. Progress in Modifying and Delivering mRNA therapies for Cancer Immunotherapy
7. mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment
8. Therapeutic mRNAs for cancer immunotherapy: from structure to delivery
9. Harnessing the immune system: Insights into cancer vaccines
10. Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy
11. Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment
12. Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy
13. Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development
14. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA and mRNA Vaccine in cancer Immunotherapy
- No. of pages: 198
- Language: English
- Edition: 1
- Volume: 165
- Published: May 1, 2025
- Imprint: Academic Press
- Hardback ISBN: 9780443344954
- eBook ISBN: 9780443344961
AS
Arun Kumar Singh
Arun Kumar Singh has completed M. Pharm (Pharmaceutics) from Galgotias University, Greater Noida, India. Mr. Singh joined as an Assistant Professor in Amity Institute of Pharmacy, Amity University, Greater Noida. His area of interest is in the area of Nano-formulation, Blockchain, IoT, Machine learning, Cancer, Artificial intelligence, Big data and Neuroscience. He has authored one book with IOP publishing. He has published 5 chapters in the field of big data with prestigious River Publisher, Denmark. He has also published 24 review papers among which two are in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. His cumulative impact factor is 85.6. He has published 28 books with publishers such as Springer, IOP, Elsevier, CRC PRESS and Wiley. His strengths are research skills, thinking innovation, leadership qualities, decision-making, and positive thinking. His hard-working nature and devotion to his work make him distinguishable and extraordinary.
NM
Neeraj Mishra
Dr. Neeraj Mishra is a Professor and Head of the Department of Pharmaceutics at Amity Institute of Pharmacy, India, a position he has held since July 2019. With nearly two decades of teaching and research experience, Dr. Mishra has authored over 100 publications on novel drug delivery systems, focusing on nanocarriers and microparticles for treating breast and colon cancer, as well as neurodegenerative disorders. He has written several books and book chapters, and holds three international and two Indian patents. Dr. Mishra has received numerous accolades, including the "Distinguished Professor Award" (2019, 2021) and the "Outstanding Scientist Award" (2020). He has served as a guest editor for Bentham Sciences and is recognized in Stanford University's World Scientists Rankings for 2022 and 2024.
SA
Sumel Ashique
Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 13 books under CRC Press, Taylor & Francis, Springer and Wiley.
PP
Pranav Kumar Prabhakar
Dr. Pranav Kumar Prabhakar is currently working as a Professor and Deputy Director at Parul University, Gujarat, India. He is one of the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, and 2024). He has completed his PhD in Biotechnology from IIT Madras. His main area of research interest focuses on elucidating molecular Mechanisms and Strategies for Oral Insulin Delivery, Mimicking the signaling pathways in Metabolic Disorders (diabetes) with Natural Products. He is a member of the Royal Society of Chemistry, and the Asia-Pacific Chemical, Biological& Environmental Engineering Society. He is also serving as an editorial board member and reviewer for many reputed national and International Journals. Dr. Pranav received honors including the recipient of a travel grant towards attending ATTD 2009 in Greece from the Indian Institute of Technology Madras & Council for Scientific and Industrial Research (CSIR) and approved by the Department of Science and Technology (DST). He has published 100+ research articles in journals, authored 8 books, and 25 book chapters. He also delivered 9 oral and poster presentations in scientific meetings.